The present study had recruited 569 patients who never took lipid-lowering drugs previously and showed that the plasma concentration of Lp-PLA2 was definitely associated with apoB or apoB/apoA1 in stable CAD subjects. The gene discussed is APOA1; the disease is coronary artery disorder.